[Federal Register Volume 83, Number 207 (Thursday, October 25, 2018)]
[Notices]
[Pages 53879-53880]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23291]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-19-0920]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Data Collection Through Web Based Surveys for 
Evaluating Act Against AIDS Social Marketing Campaign Phases Targeting 
Consumers to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on June 6, 
2018 to obtain comments from the public and affected agencies. CDC 
received one comment related to the previous notice. This notice serves 
to allow an additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:

    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden 
of the proposed collection of information, including the validity of 
the methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information 
to be collected;
    (d) Minimize the burden of the collection of information on 
those who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., 
permitting electronic submission of responses; and
    (e) Assess information collection costs.

    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Data Collection Through Web Based Surveys for Evaluating Act 
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB 
#0920-0920, Exp. 6/30/2018)--Reinstatement with Change--National Center 
for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    In response to the continued HIV epidemic in our country, CDC 
launched Act Against AIDS (AAA), a multifaceted communication campaign 
to reduce HIV incidence in the United States in 2009. CDC has released 
the campaign in phases, with some of the phases running concurrently. 
Each phase of the campaign uses mass media and direct-to-consumer 
channels to deliver messages. Some campaigns provide basic education 
and increase awareness of HIV/AIDS among the general public, whereas 
others emphasize HIV prevention and testing among specific subgroups or 
communities at greatest risk of infection. CDC will also develop new 
messages to address changes in prevention science and subpopulations 
affected by HIV. The proposed study will assess the effectiveness of 
these social marketing messages aimed at increasing HIV/AIDS awareness, 
increasing prevention behaviors, and improving HIV testing rates among 
consumers.
    The reinstatement with change of this ongoing study will allow for 
continued evaluation of the effectiveness of AAA social marketing 
campaign through surveys with consumers. A total of 10,750 respondents 
were approved for the previously renewed generic ICR (0920-0920) and 
since the approval date, 4,305 respondents were surveyed under the 
GenIC, ``Development of Messages for the Act Against AIDS National 
Testing''. The information collected from these data collections was 
used to evaluate a specific AAA campaign phase. We are requesting the 
same amount of time to continue surveying AAA target audiences as new 
phases are developed.
    Through the continuation of this collection, we plan to reach the 
remaining approved 6,445 respondents. To obtain the remaining 
respondents, we anticipate screening approximately 32,220 individuals. 
Depending on the target audience for the campaign phase, the study 
screener will vary. The study screener may address one or more of the 
following items: Race/ethnicity, sexual behavior, sexual orientation, 
gender identity, HIV testing history, HIV status, and injection drug 
use. Each survey will have a core set of items asked in all rounds, as 
well as a module of questions relating to specific AAA phases and 
activities.
    Respondents will be recruited through national opt-in email lists, 
the internet, and external partnerships with community-based and 
membership organizations that work with or represent individuals from 
targeted populations (e.g., National Urban League, the National Medical 
Association). Respondents will self-administer the survey at home on 
personal computers. There is no cost to the respondents other than 
their time. The total annualized burden hours are 1,432.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) aged 18   Study Screener..........          10,740               1            2/60
 years and older.
                                        Survey..................           2,148               1           30/60
----------------------------------------------------------------------------------------------------------------



[[Page 53880]]

Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of 
Scientific Integrity, Office of the Associate Director for Science, 
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-23291 Filed 10-24-18; 8:45 am]
 BILLING CODE 4163-18-P